Post
24 Upvote

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

Downvote
nejm.org/doi/full/10.1056/NEJMoa2304594

This story from nejm.org was posted on 2023-06-05 by @ivyvine.

Comments

The Entire Business World on a Single Page. Free to Use →